QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-brainsway-maintains-16-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $16 price tar...

 hc-wainwright--co-maintains-buy-on-brainsway-raises-price-target-to-16

HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target ...

 northland-capital-markets-maintains-outperform-on-brainsway-raises-price-target-to-11

Northland Capital Markets analyst Carl Byrnes maintains BrainsWay (NASDAQ:BWAY) with a Outperform and raises the price targe...

 brainsway-raises-lower-end-of-fy24-revenue-guidance-to-range-of-385m---40m-est-38323m

Anticipating continued profitability momentum and positive cash generation throughout the second half of 2024.

 brainsway-q2-gaap-eps-004-up-from-010-yoy-sales-1001m-beat-925m-estimate

BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.04 per share. This is a 140 percent increase over losses of $(0.10) p...

 brainsway-files-for-mixed-shelf-of-up-to-100m

-SEC Filing

 hc-wainwright--co-reiterates-buy-on-brainsway-maintains-15-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $15 price tar...

 brainsway-says-fda-has-granted-expanded-indication-for-deep-transcranial-magnetic-stimulation-system

This allows for the treatment of patients with major depressive disorder (MDD) ages 22 to 86, changing the previous upper age l...

 oppenheimer-maintains-outperform-on-brainsway-raises-price-target-to-11

Oppenheimer analyst Steven Lichtman maintains BrainsWay (NASDAQ:BWAY) with a Outperform and raises the price target from $10...

 hc-wainwright--co-maintains-buy-on-brainsway-raises-price-target-to-15

HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target ...

 brainsway-reiterates-fy24-revenue-guidance-of-37m-40m-est-37779m

This would represent growth of 16% to 26% over full-year 2023 revenue. In addition, it continues to anticipate that profitabili...

 brainsway-q1-sales-9095m-beat-8720m-estimate

BrainsWay (NASDAQ:BWAY) reported quarterly sales of $9.095 million which beat the analyst consensus estimate of $8.720 million ...

 brainsway-expands-deep-tms-access-in-israel-brainsway-has-steadily-increased-its-presence-in-the-country-with-11-recent-system-installations-driven-in-part-by-a-45-increase-in-reimbursement-rates

 BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasi...

 brainsway-announces-published-review-results-highlighting-potential-of-deep-tms-to-treat-parkinsons-disease

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasiv...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION